Aberrant expression of CDX2 in metaplastic and inflammatory epithelium of the urinary bladder.

H. Steininger,H. Mueller,L. Marquardt

DOI: https://doi.org/10.1097/01.PAS.0000162242.31810.D4

2005-09-01

Abstract:We read with great interest the article by Phillips et al, published 2003 in this journal and the letter to the editor by Osawa et al in the September 2004 issue. The authors reported that CDX2 was a sensitive marker of intestinal metaplasia in the esophagus as well as in the gallbladder. Transitional epithelium of the urinary bladder is also prone to metaplastic changes and intestinal metaplasia of the urothelium, often together with cystic changes, is resulting from chronic inflammation and other irritation of the mucosa. Extensive intestinal metaplasia in the urinary bladder is a significant risk factor for the development of adenocarcinoma. Werling et al found CDX2 staining in 100% of urinary adenocarcinomas, and Ortiz-Rey et al observed expression of CDX2 in intestinal metaplasia of the urinary bladder as well as in bladder adenocarcinoma but not in normal urothelium. We studied biopsies from the urinary bladder of three cases with marked chronic inflammation. In intestinal metaplasia of cystitis glandularis (Fig. 1a), we identified in goblet cells strong expression of CK20, MUC2, and nuclear staining of CDX2. Multiple foci of intestinal metaplasia could be observed. In nonmetaplastic inflammatory transitional epithelium, distinct nuclear expression of CDX2 was present (Fig. 1b) and, sometimes, fine granular cytoplasmic immunoreactivity could be seen in the vicinity. The staining intensity ranged from about 50% to 100%. The nonmetaplastic urothelium displaying CDX2 was mostly hyperplastic with cuboidal or columnar epithelium. Expression of CDX2 in this urothelium was multifocal and always associated with different degrees of inflammation. It was found adjacent to foci of intestinal metaplasia but also separate from it and within the epithelium of von Brunn’s nests. No positivity for CK20 and MUC2 was found in the inflamed urothelium. This observation is in accordance with reports that CDX2 emerges already at the stage of inflammation and induces the differentiation of goblet cell. Taken together, expression of CDX2 indicates, probably, the key molecular event that causes a distinct epithelial pathway to result. CDX2 may arise as the result of chronic injury and may be responsible for initiating the differentiation pathway of intestinal metaplasia in the urothelium.